The MarketWatch News Department was not involved in the creation of this content.
Dec 15, 2020 (NewMediaWire via COMTEX) —
San Diego, CA – (NewMediaWire (https://www.newmediawire.com)) – December 15, 2020 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds(R) has launched the rebranding of its globally recognized hemp-derived cannabidiol (CBD) products as part of its recent shift in consumer strategy and executive leadership.
“As the CBD industry continues to expand exponentially throughout the world, especially in the US and Latin America, we saw an opportunity to further leverage Raul Elizalde’s tremendous experience in the CBD industry by positioning him as the sole CEO of HempMeds. This is an exciting new direction for the Company which comes with new initiatives and activities such as updated branding, new products and digital events in 2021,” said HempMeds(R) Co-Founder Michelle Sides. “We are confident that consumers will respond positively to the new HempMeds branding as we continue pushing the industry forward as have since founding the company to help trailblaze the CBD market many years…
Original Author Link click here to read complete story..
